Mutations in the Steroidogenic Acute Regulatory Protein (StAR) in Six Patients with Congenital Lipoid Adrenal Hyperplasia1
Himangshu S. Bose2,
Seiji Sato,
Javier Aisenberg,
Stavit A. Shalev,
Nobutake Matsuo and
Walter L. Miller
Department of Pediatrics and Metabolic Research Unit, University of
California (H.S.B., W.L.M.), San Francisco, California 94143-0978;
Department of Pediatrics, Keio University Medical School (S.S., N.M.),
Tokyo 160, Japan; Hackensack University Medical Center (J.A.),
Hackensack, New Jersey 07601; and HaEmek Medical Center
(S.A.S.), Afula 18101, Israel
Address all correspondence and requests for reprints to: Prof. Walter L. Miller, Department of Pediatrics, Building MR IV, Room 205, University of California, San Francisco, California 94143-0978.
Congenital lipoid adrenal hyperplasia (lipoid CAH), the mostsevere
form of CAH, is caused by mutations in the steroidogenicacute
regulatory protein (StAR). Lipoid CAH is common amongthe Japanese,
Korean, and Palestinian Arab populations, butis rare elsewhere. We
describe six patients with lipoid CAH:four Japanese, one Palestinian,
and one Guatemalan Native American.All had classical clinical
presentations of normal female externalgenitalia in both genetic
sexes, with severe glucocorticoidand mineralocorticoid deficiency
presenting in the first monthof life. Quite atypically, one patient
had small adrenal glandsshown by computed tomographic scanning. The
StAR genes werecharacterized in all six patients. Three of the
Japanese patientswere compound heterozygotes for the common Japanese
mutationQ258X in association with three different novel frameshift
mutations;the fourth Japanese patient was homozygous for the mutation
R182L,which is common among Palestinian patients but has not been
describedpreviously in a Japanese patient. Our Palestinian and Native
Americanpatients were each homozygous for novel frameshift mutations.
Thuswe have found five new frameshift mutations, but no new aminoacid
replacement (missense) mutations. This would be consistentwith the
view that only a small number of residues in the StARprotein are
crucial for biological activity. The tomographicfinding of small
adrenals in a patient with genetically provenlipoid CAH due to a StAR
mutation suggests a substantially broaderspectrum of clinical findings
in this disease than has beenappreciated previously.
This article has been cited by other articles:
S. Bens, A. Mohn, B. Yuksel, A. E. Kulle, M. Michalek, F. Chiarelli, M. Nuri Ozbek, I. Leuschner, J. Grotzinger, P.-M. Holterhus, et al. Congenital Lipoid Adrenal Hyperplasia: Functional Characterization of Three Novel Mutations in the STAR Gene
J. Clin. Endocrinol. Metab.,
March 1, 2010;
95(3):
1301 - 1308.
[Abstract][Full Text][PDF]
P. R. Manna, I. T. Huhtaniemi, and D. M. Stocco Mechanisms of Protein Kinase C Signaling in the Modulation of 3',5'-Cyclic Adenosine Monophosphate-Mediated Steroidogenesis in Mouse Gonadal Cells
Endocrinology,
July 1, 2009;
150(7):
3308 - 3317.
[Abstract][Full Text][PDF]
G. Sasaki, T. Ishii, P. Jeyasuria, Y. Jo, A. Bahat, J. Orly, T. Hasegawa, and K. L. Parker Complex Role of the Mitochondrial Targeting Signal in the Function of Steroidogenic Acute Regulatory Protein Revealed by Bacterial Artificial Chromosome Transgenesis in Vivo
Mol. Endocrinol.,
April 1, 2008;
22(4):
951 - 964.
[Abstract][Full Text][PDF]
C. J. Kim, L. Lin, N. Huang, C. A. Quigley, T. W. AvRuskin, J. C. Achermann, and W. L. Miller Severe Combined Adrenal and Gonadal Deficiency Caused by Novel Mutations in the Cholesterol Side Chain Cleavage Enzyme, P450scc
J. Clin. Endocrinol. Metab.,
March 1, 2008;
93(3):
696 - 702.
[Abstract][Full Text][PDF]
M. Abdulhadi-Atwan, A. Jean, W. K. Chung, K. Meir, Z. Ben Neriah, G. Stratigopoulos, S. E. Oberfield, I. Fennoy, H. J. Hirsch, A. Bhangoo, et al. Role of a Founder c.201_202delCT Mutation and New Phenotypic Features of Congenital Lipoid Adrenal Hyperplasia in Palestinians
J. Clin. Endocrinol. Metab.,
October 1, 2007;
92(10):
4000 - 4008.
[Abstract][Full Text][PDF]
M. Bose, D. Debnath, Y. Chen, and H. S Bose Folding, activity and import of steroidogenic acute regulatory protein into mitochondria changed by nicotine exposure
J. Mol. Endocrinol.,
July 1, 2007;
39(1):
67 - 79.
[Abstract][Full Text][PDF]
B. Y. Baker, R. F. Epand, R. M. Epand, and W. L. Miller Cholesterol Binding Does Not Predict Activity of the Steroidogenic Acute Regulatory Protein, StAR
J. Biol. Chem.,
April 6, 2007;
282(14):
10223 - 10232.
[Abstract][Full Text][PDF]
B. Y. Baker, L. Lin, C. J. Kim, J. Raza, C. P. Smith, W. L. Miller, and J. C. Achermann Nonclassic Congenital Lipoid Adrenal Hyperplasia: A New Disorder of the Steroidogenic Acute Regulatory Protein with Very Late Presentation and Normal Male Genitalia
J. Clin. Endocrinol. Metab.,
December 1, 2006;
91(12):
4781 - 4785.
[Abstract][Full Text][PDF]
H. Morgan, V. Battista, and S. S. Leopold Constraint in Primary Total Knee Arthroplasty
J. Am. Acad. Ortho. Surg.,
December 1, 2005;
13(8):
515 - 524.
[Abstract][Full Text][PDF]
A. Bhangoo, W.-X. Gu, S. Pavlakis, H. Anhalt, L. Heier, S. Ten, and J. L. Jameson Phenotypic Features Associated with Mutations in Steroidogenic Acute Regulatory Protein
J. Clin. Endocrinol. Metab.,
November 1, 2005;
90(11):
6303 - 6309.
[Abstract][Full Text][PDF]
C. E. Fluck, A. Maret, D. Mallet, S. Portrat-Doyen, J. C. Achermann, B. Leheup, G. E. Theintz, P. E. Mullis, and Y. Morel A Novel Mutation L260P of the Steroidogenic Acute Regulatory Protein Gene in Three Unrelated Patients of Swiss Ancestry with Congenital Lipoid Adrenal Hyperplasia
J. Clin. Endocrinol. Metab.,
September 1, 2005;
90(9):
5304 - 5308.
[Abstract][Full Text][PDF]
X. Chen, B. Y. Baker, M. A. Abduljabbar, and W. L. Miller A Genetic Isolate of Congenital Lipoid Adrenal Hyperplasia with Atypical Clinical Findings
J. Clin. Endocrinol. Metab.,
February 1, 2005;
90(2):
835 - 840.
[Abstract][Full Text][PDF]
Y. Jo and D. M. Stocco Regulation of Steroidogenesis and Steroidogenic Acute Regulatory Protein in R2C Cells by DAX-1 (Dosage-Sensitive Sex Reversal, Adrenal Hypoplasia Congenita, Critical Region on the X Chromosome, Gene-1)
Endocrinology,
December 1, 2004;
145(12):
5629 - 5637.
[Abstract][Full Text][PDF]
S. R. King, S. D. Ginsberg, T. Ishii, R. G. Smith, K. L. Parker, and D. J. Lamb The Steroidogenic Acute Regulatory Protein Is Expressed in Steroidogenic Cells of the Day-Old Brain
Endocrinology,
October 1, 2004;
145(10):
4775 - 4780.
[Abstract][Full Text][PDF]
A. A. Gonzalez, M. L. Reyes, C. A. Carvajal, J. A. Tobar, L. M. Mosso, P. Baquedano, A. Solar, A. Venegas, and C. E. Fardella Congenital Lipoid Adrenal Hyperplasia Caused by a Novel Splicing Mutation in the Gene for the Steroidogenic Acute Regulatory Protein
J. Clin. Endocrinol. Metab.,
February 1, 2004;
89(2):
946 - 951.
[Abstract][Full Text][PDF]
T. Ishii, T. Hasegawa, C.-I Pai, N. Yvgi-Ohana, R. Timberg, L. Zhao, G. Majdic, B.-c. Chung, J. Orly, and K. L. Parker The Roles of Circulating High-Density Lipoproteins and Trophic Hormones in the Phenotype of Knockout Mice Lacking the Steroidogenic Acute Regulatory Protein
Mol. Endocrinol.,
October 1, 2002;
16(10):
2297 - 2309.
[Abstract][Full Text][PDF]
S. L. Gyles, C. J. Burns, B. J. Whitehouse, D. Sugden, P. J. Marsh, S. J. Persaud, and P. M. Jones ERKs Regulate Cyclic AMP-induced Steroid Synthesis through Transcription of the Steroidogenic Acute Regulatory (StAR) Gene
J. Biol. Chem.,
September 7, 2001;
276(37):
34888 - 34895.
[Abstract][Full Text][PDF]